Completed PHASE2 INTERVENTIONAL NCT00078585

PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

A Phase II Randomized, Double Blind, Controlled Study to Evaluate the Safety and Efficacy of PROSTVAC®-VF/TRICOM™ in Combination With GM-CSF in Patients With Androgen-Independent Adenocarcinoma of the Prostate

Sponsor: Bavarian Nordic

Conditions Prostate Cancer

Interventions PROSTVAC®-VF/TRICOM™

Updated 7 times since 2017 Last updated: Sep 7, 2017 Started: Nov 30, 2003 Primary completion: Jan 4, 2006 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Prostate Cancer and is currently completed. Bavarian Nordic leads this study, which shows 7 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Oct 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Jan 2017 — Oct 2017 [monthly]

Unknown Status PHASE2

First recorded

Nov 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bavarian Nordic
National Cancer Institute (NCI)
Therion Biologics Corporation

Data source: Bavarian Nordic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Albuquerque, United States , Anchorage, United States , Arlington, United States , Atlanta, United States , Aurora, United States , Aventura, United States , Baltimore, United States , Boston, United States , Charleston, United States and 34 more locations